Public figure
What Saku Koivu's Story Can Help Us Understand About Non-Hodgkin Lymphoma
The hockey captain was treated for non-Hodgkin lymphoma and returned to a legendary ovation. Here is what that cancer means, explained calmly.
Please note: this page is educational only — it is not medical advice, and it does not speculate about anyone’s health beyond reliable public reporting. For questions about your own health, talk with your healthcare team.
The news
Saku Koivu was the longtime captain of the Montreal Canadiens and one of Finland's most celebrated hockey players. In September 2001 he was diagnosed with a non-Hodgkin lymphoma and missed nearly the entire 2001–02 season for treatment. He returned near the end of that season, and fans greeted him with a long, emotional standing ovation. For his courage and leadership through treatment, he was later awarded the Bill Masterton Memorial Trophy.
That is what has been publicly reported. We do not speculate about private medical details beyond what has been shared.
Why people are talking about it
Koivu's return to the ice, and the ovation that greeted him, became one of the most memorable moments in hockey. His story is often cited when non-Hodgkin lymphoma comes up, and it has offered encouragement to many people facing the disease.
What this cancer means
According to the National Cancer Institute, lymphoma is a broad term for cancer that begins in cells of the lymph system. NCI explains that the two main types are Hodgkin lymphoma and non-Hodgkin lymphoma (NHL), and that the prognosis of NHL depends on the specific type, of which there are many. Understanding which type is present, and what stage it is, is something a healthcare team can explain for any individual.
What to remember
Every person's situation is different, and one athlete's comeback cannot tell any individual how their own illness will unfold. Koivu's story is not medical advice. What it can do is remind people that non-Hodgkin lymphoma is a real and varied group of cancers, and that treatment can make a meaningful difference for many.
Awareness, screening, and prevention
NCI states that it does not have evidence-based information about screening for or prevention of lymphoma, and points readers to its general cancer screening and prevention overviews. In other words, there is no routine screening test for lymphoma. Paying attention to persistent symptoms, such as swollen lymph nodes, and raising them with a healthcare professional is a practical habit. Our free screening check-up tool is a gentle way to think through what health conversations may be worth having.
Turning a story into something useful
Understanding that lymphoma has two main types, that non-Hodgkin lymphoma includes many subtypes, and that persistent symptoms deserve attention are calm, practical takeaways. Supporting free, trustworthy cancer education helps this reach more people.
Questions to ask a healthcare team
- What symptoms might be worth investigating?
- What does it mean that there are many types of non-Hodgkin lymphoma?
- What does treatment generally involve?
- Where can I find reliable, plain-language information about lymphoma?